318 results on '"Genda, Takuya"'
Search Results
2. Allograft liver failure awaiting liver transplantation in Japan
3. FRI-272 Steatotic liver disease with normal liver enzyme: clinical use of ultrasound attenuation method and share wave elastography
4. Hepatitis B surface antigen (HBsAg) glycan isomer is predictive of HBsAg seroclearance in patients with chronic hepatitis B
5. Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease
6. Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapy
7. Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria
8. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
9. A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis
10. A case of ischemic gastroduodenal disease in a patient who was receiving hemodialysis treatment that was managed by conservative treatment
11. Clinical features of non-obese NAFLD: analysis of health check-up cohort
12. A new glyco-biomarker for measuring infectious hepatitis B virus targeting surface antigen glycan isomer (HBsAgGi)
13. Elevated serum procalcitonin levels and their association with the prognosis of patients with liver cirrhosis
14. Revisions of the clinical practice guidelines for hepatocellular carcinoma in 2021 version
15. Retrograde Transcaval Obliteration for Refractory Hepatic Encephalopathy with Multiple Intrahepatic Portosystemic Venous Shunts: A Case Report
16. Isolated adrenocorticotropic hormone deficiency associated with atezolizumab and bevacizumab administration for treating hepatocellular carcinoma: a case series
17. Liver Transplantation for Primary Biliary Cirrhosis
18. Early‐phase prothrombin time‐international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement
19. Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy
20. No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy
21. Sofosbuvir–velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan
22. Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease
23. Survival in patients with Child–Pugh class C cirrhosis: Analysis of the liver transplant registry in Japan
24. Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines).
25. Clinical practice guidelines for autoimmune hepatitis
26. Tu1084: THE DIFFERENCE OF GASTRIC MUCOSAL INJURIES BETWEEN PATIENTS TAKING ASPIRIN ALONE, CLOPIDOGREL ALONE AND BOTH AGENTS (DUAL ANTIPLATELET THERAPY: DAPT)
27. Diagnostic Criteria for Acute-on-Chronic Liver Failure and Related Disease Conditions in Japan
28. Mo1229 CHARACTERISTICS OF ENDOSCOPIC FINDINGS OF PPI/P-CAB-RELATED GASTROPATHY FOR PATIENTS USING EACH ANTACID
29. Aldo‐keto reductase family 1 member B10 is associated with hepatitis B virus‐related hepatocellular carcinoma risk
30. Early‐phase prothrombin time‐international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement.
31. Mediastinal pancreatic pseudocyst diagnosed based on black pleural effusion.
32. Serum O-Glycosylated Hepatitis B Surface Antigen Levels in Patients with Chronic Hepatitis B During Nucleos(t)ide Analog Therapy
33. Hepatitis B Surface Antigen Decline during Sofosbuvir and Ribavirin Therapy in Hepatitis B Inactive Carriers Who Were Co-infected with Hepatitis C
34. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system
35. Revised criteria for classification of the etiologies of acute liver failure and late-onset hepatic failure in Japan: A report by the Intractable Hepato-biliary Diseases Study Group of Japan in 2015
36. Clinical significance of cell cycle inhibitors in hepatocellular carcinoma
37. # 1068 Treatment with the single-tablet regimen ledipasvir/sofosbuvir for 12 weeks results in 100% sustained virologic response in Japanese patients with chronic genotype-1 hepatitis C virus infection
38. # 1076 Sofosbuvir in combination with ribavirin for 12 weeks achieves 97% sustained virologic response in Japanese patients with chronic genotype 2 hepatitis C infection
39. Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication
40. Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure
41. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
42. Differences in the factors associated with serum viral load between genotypes 1 and 2 in patients with chronic hepatitis C
43. Indications and waiting list priority for deceased donor liver transplantation in HIV/HCV co‐infected hemophilic patients in Japan through contaminated blood product
44. A case of gastric adenocarcinoma of fundic-gland mucosa type
45. Elevated serum tyrosine concentration is associated with a poor prognosis among patients with liver cirrhosis
46. Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy
47. Diagnostic criteria for acute‐on‐chronic liver failure and related disease conditions in Japan.
48. Post-treatment Mac-2-Binding Protein is a Useful Predictor of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication
49. Does restricting fluid volume impact post-ERCP pancreatitis in patient with heart disease?
50. FRI-257 - A new glyco-biomarker for measuring infectious hepatitis B virus targeting surface antigen glycan isomer (HBsAgGi)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.